Onychomycosis ( also known as " dermatophytic onychomycosis, " or " tinea unguium " It is the most common disease of the nails and constitutes about half of all nail abnormalities.
22.
Other infections could also occur, such as onychomycosis and otomycosis . " A . terreus " has the ability to cause serious effects in immunocompromised patients who lack specific immune cells.
23.
The fungus is encountered rarely as a confirmed agent of onychomycosis in which the infection is validated by both a direct observation of filaments in the nail and recovery of the fungus in culture.
24.
Onychomycosis can occur under the fingernails, but it is far more common in toes, doctors say, because the feet are more often subject to the dark, warm, moist conditions that fungi favor.
25.
A carbon dioxide laser ( CO 2 ) is used in surgery to treat onychocryptosis ( ingrown nails ), onychauxis ( club nails ), onychogryposis ( rams horn nail ), and onychomycosis ( fungus nail ).
26.
For that, you can thank all those close-up, full-color photos of onychomycosis-stricken feet _ brought to you courtesy of Janssen Pharmaceutica, a unit of consumer-products giant Johnson & Johnson, makers of the anti-fungal Sporanox.
27.
There are two types, longitudinal and transverse melanonychia . although there are other diagnoses such as chronic paronychia, onychomycosis, subungual hematoma, pyogenic granuloma, glomus tumour, subungual verruca, mucous cyst, subungual fibroma, keratoacanthoma, carcinoma of the nail bed, and subungual exostosis.
28.
Amorolfine 5 % nail lacquer in once-weekly or twice-weekly applications has been shown in two studies to be between 60 % and 71 % effective in treating toenail onychomycosis; complete cure rates three months after stopping treatment ( after six months of treatment ) were 38 % and 46 %.
29.
In 2014, the U . S . Food and Drug Administration ( FDA ) approved the New Drug Application ( NDA ) for Jublia, the " first topical triazole approved for the treatment of onychomycosis of the toenails . " According to Valeant Pharmaceuticals International Inc CEO J . Michael Pearson they acquired Jublia through their purchase of Dow Pharmaceutical Sciences in 2008.
30.
"Trichophyton rubrum " and " Trichophyton interdigitale " cause athlete's foot ( tinea pedis ), toenail fungal infections ( a . k . a . tinea unguium, a . k . a . onychomycosis ), crotch itch ( a . k . a . tinea cruris ), and ringworm ( a misnomer, as there is no worm involved; it is also known as tinea corporis ).
